Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

Digital content for Servier

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Servier
France Flag
Country
Country
France
Address
Address
50 rue Carnot Suresnes, 92150
Telephone
Telephone
+33 1 55 72 60 00

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

left grey arrow
right gray arrow

https://www.prnewswire.com/news-releases/servier-highlights-commitment-to-improving-cancer-outcomes-at-asco-2024-302153468.html

PR NEWSWIRE
23 May 2024

https://www.fiercepharma.com/marketing/et-voila-new-name-takes-top-spot-reputation-ranking-us-patient-groups

Nick Paul Taylor FIERCE PHARMA
14 May 2024

https://www.prnewswire.com/news-releases/servier-ranks-1st-across-several-categories-in-2023-2024-patientview-us-corporate-reputation-survey-302144762.html

PR NEWSWIRE
14 May 2024

https://www.20minutes.fr/economie/4087038-20240418-biogaran-poids-lourd-francais-medicaments-generiques-vendu-groupe-etranger

20MINUTES
18 Apr 2024

https://www.prnewswire.com/news-releases/servier-data-presented-at-aacr-underscores-unwavering-dedication-to-advancing-oncology-rd-302109436.html

PR NEWSWIRE
08 Apr 2024

https://www.prnewswire.com/news-releases/servier-receives-regulatory-filing-acceptances-from-fda-and-ema-for-vorasidenib-in-the-treatment-of-idh-mutant-diffuse-glioma-302068104.html

PR NEWSWIRE
21 Feb 2024

https://www.prnewswire.com/news-releases/fda-and-ema-accept-vorasidenib-regulatory-submissions-for-the-treatment-of-idh-mutant-diffuse-glioma-302064504.html

PR NEWSWIRE
20 Feb 2024

https://www.prnewswire.com/news-releases/servier-and-base4-expand-partnership-to-advance-neuroscience-drug-development-302027491.html

PR NEWSWIRE
05 Jan 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/french-drugmaker-servier-ordered-pay-471-million-mediator-scandal-2023-12-20/

REUTERS
21 Dec 2023

https://www.prnewswire.com/news-releases/servier-showcases-leadership-in-mutant-isocitrate-dehydrogenase-idh-inhibition-through-new-data-spotlighting-real-world-treatment-patterns-and-clinical-outcomes-of-tibsovo-use-at-ash-2023-302010716.html

PR NEWSWIRE
09 Dec 2023
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY